卢浩波
He liked
US DOLLAR SEES MILD GAINS FOLLOWING JOBLESS CLAIMS, LESS HAWKISH POWEL
Fed Chair Powell signals inflation still remains high despite significant easing, suggesting an uncertain path forward.Powell acknowledges that strict monetary policy has balanced both inflation and an overheated economy, leveling dual goal risks.Weekly Initial Jobless Claims came in steady. The&nbs
He liked
USD/TRY: TRADING WITHIN A LONG-TERM UPTREND
ScenarioTimeframeWeeklyRecommendationBUY STOPEntry Point32.0315Take Profit32.8125, 33.2031Stop Loss31.7369Key Levels30.4687, 30.8593, 31.6406, 32.0312, 32.8125, 33.2031Alternative scenarioRecommendationSELL STOPEntry Point31.6405Take Profit30.8593, 30.4687Stop Loss31.9300Key Levels30.4687, 30.8593,
He liked
Prospek GBP/USD pada 12 Maret. Apakah Pound sedang menuju ke bawah?
Analisis GBP/USD 5M GBP/USD memulai pergerakan turun pada hari Senin dan bahkan menembus garis tren. Namun, hal ini tidak terlalu berarti karena garis tren memiliki sudut yang sangat curam, sehingga hampir semua retracement ke bawah akan menghasilkan terobosan. Hal krusialnya adalah harga terus bert
He liked
出海效果显著,康方生物预计23年盈利不低于18.5亿 | 见智研究
3月5日,双抗龙头康方生物(9926.HK)宣布了其2023年度令人瞩目的财务成绩。 得益于公司双抗出海,预计2023年度将实现至少18.5亿元人民币的利润,意味着康方生物从上一财年的14.2亿元人民币亏损中成功扭亏为盈,并成为公司上市以来首个盈利财年。 2023年度的转亏为盈的来源为两个关键因素: 1、公司与美国Summit Therapeutics公司就其核心自主研发的双抗药物依达方®(依沃西,PD-1/VEGF)达成的海外权益许可合作,交易总额高达50亿美元,加上销售净额的双位数比例提成。 该合作的首付款5亿美元在2023年一季度收到,其中大部分已确认为约29亿元人民币的许可费收入,剩余
He liked
AUD/USD PRICE ANALYSIS: TURNS SIDEWAYS NEAR FRESH TWO-WEEK HIGH AROUND 0.6550
AUD/USD trades back and forth near weekly high ahead of the Fed and the RBA minutes. The reopening of Chinese markets has provided some strength to the Australian Dollar. Stubborn US price pressures fail to provide support to the US Dollar. The AUD/USD pair consolidates in a narrow range after a sha
He liked
He liked
NZD/USD TO MOVE HIGHER EVEN IN THE CASE OF AN RBNZ DOVISH SHIFT – ING
New Zealand's Consumer Price Index (CPI) eased further in the fourth quarter of 2023. NZD/USD broke back above 0.6100 on the release. Economists at ING analyze the pair’s outlook. Non-tradeable inflation offers RBNZ a hawkish "loophole" New Zealand’s inflation matched estimates at 0.5% quarter-on-qu
He liked
He liked
He liked
The best platform for stock CFD trading revealed: JRFX
In today's financial market, stock CFD trading is gradually becoming a popular investment method among investors. However, choosing a reliable and efficient trading platform is the key to successfully making this type of investment. Today, we will reveal to you the JRFX foreign exchange platform - a
He liked
Industri Sawit RI Punya Potensi Jumbo, Tapi...
Foto: Minamas Plantation Jakarta Pemerintah Indonesia menargetkan pada 2025 mendatang produksi kelapa sawit Indonesia tembus 50 juta ton dengan syarat tidak adanya penambahan lahan. Namun untuk mencapai angka tersebut, ada sejumlah tantangan yang harus diselesaikan. Kepala Divisi Program Pelayanan B
He liked
He liked
美国CPI数据前瞻:投行预计核心通胀增速可能再度加速,美联储面临再次加息风险
汇通财经APP讯——就在消费者对通胀的预期上升之际,华尔街投行正在为周二(11月14日)公布的10月份消费者价格指数(CPI)可能反映出美联储面临的潜在问题做准备。 原因在于,剔除食品和能源价格波动的核心CPI指数预计不会出现变动。核心指数更能反映通胀趋势。巴克莱、法国巴黎银行和美国银行证券预计,上个月的核心通胀率较上年同期上涨4.2%,略高于经济学家的预期。上月的核心通胀率要么维持在0.3%,要么小幅上升至0.4%。 更重要的是,被称为“超级核心通胀率”(supercore inflation)的较弱指标预计将再次远高于美联储2%的目标。“超级核心通胀率”是衡量不包括能源和住房在内的服务业的
Pull-up Update